Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "redox-biology"

2 News Found

NADMED Limited appoints James Lee as CEO to drive global expansion
People | April 29, 2026

NADMED Limited appoints James Lee as CEO to drive global expansion

Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation

NADMED forms global Scientific Advisory Board to advance redox diagnostics and precision medicine
R&D | April 21, 2026

NADMED forms global Scientific Advisory Board to advance redox diagnostics and precision medicine

The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways

Latest Stories

Pawan Varshney elevated to Director of Finance – South Asia at Cepheid

Nitin Wadhwa joins Sebia as General Manager to lead India growth

PFCD panel flags insurance gaps limiting access to robotic joint replacement in India

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi
Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi
Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi
Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India
Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India
Kavinder Beniwal Chief Operational Officer, Motorica India
Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics
Betting on NK-cell innovation and combination immunotherapy to build global clinical-stage biotech: Dr Maloy Ghosh, CSO, Zumutor Biologics
Dr Maloy Ghosh Chief Scientific Officer, Zumutor Biologics

Packaging